You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 3, February 14, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (32)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

Marked Declines in Human Immunodeficiency Virus–Related Mortality in Chicago in Women, African Americans, Hispanics, Young Adults, and Injection Drug Users, From 1995 Through 1997

Steven Whitman, PhD; James Murphy, MPH; Mardge Cohen, MD; Renslow Sherer, MD

Arch Intern Med. 2000;160:365-369.

Background  Declines in human immunodeficiency virus (HIV)–related mortality between 1995 and 1996 were seen across the United States but were small to nonexistent among people in marginalized sectors who are most likely to contract HIV and die of its effects. No comprehensive analysis describing HIV-related mortality in 1997 was available.

Objective  To describe Chicago's HIV-related mortality trends up to and including 1997, with specific attention focused on marginalized populations.

Methods  An analysis of cross-sectional HIV-related mortality data with emphasis on the years 1995 through 1997 was conducted for Chicago, Ill. Numbers, proportions, and rates of declines in HIV-related deaths were examined for the city as a whole and also among those diagnosed at Cook County Hospital, as a proxy for people with very low socioeconomic status.

Results  Between 1995 and 1996 there was an overall decline of 19% in HIV-related mortality in Chicago but small or no declines among women, African Americans, Hispanics, injection drug users, and people aged 20 to 29 years and more than 50 years. Between 1995 and 1997 there was an overall decline of 61%. At that time the declines were spread more evenly across diverse groups. There were almost no significant differences between the declines for these groups at Cook County Hospital and in the rest of Chicago.

Conclusions  The HIV-related mortality has fallen dramatically in Chicago since 1995, the year of its maximum. During 1997, declines were seen among all groups. Declines were also seen among the most disenfranchised of the city. Access to care and the new combination therapies are apparently sustaining life for many in Chicago.


From the HIV/AIDS Surveillance and Epidemiology Programs, Chicago Department of Public Health, Chicago, Ill (Dr Whitman and Mr Murphy); Women and Children HIV Program, The Core Center at Cook County Hospital, Division of General Medicine/Primary Care, Department of Medicine, Cook County Hospital, Chicago (Dr Cohen); and The Core Center at Cook County Hospital, Division of Infectious Disease, Department of Medicine, Cook County Hospital and Rush Medical College, Chicago (Dr Sherer).


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(3):397-398.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Kitahata et al.
Int J Epidemiol 2008;37:948-955.
FULL TEXT  

Effectiveness of Highly Active Antiretroviral Therapy among Injection Drug Users with Late-Stage Human Immunodeficiency Virus Infection
Vlahov et al.
Am J Epidemiol 2005;161:999-1012.
ABSTRACT | FULL TEXT  

Medically Eligible Women Who Do Not Use HAART: The Importance of Abuse, Drug Use, and Race
Cohen et al.
Am. J. Public Health 2004;94:1147-1151.
ABSTRACT | FULL TEXT  

A systematic review of complication risks for HIV-positive patients undergoing invasive dental procedures
PATTON et al.
Journal of the American Dental Association 2002;133:195-203.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.